デフォルト表紙
市場調査レポート
商品コード
1166090

医療分析試験サービスの世界市場:現状分析と予測(2022年~2028年)

Healthcare Analytical Testing Services Market: Current Analysis and Forecast (2022-2028)

出版日: | 発行: UnivDatos Market Insights Pvt Ltd | ページ情報: 英文 154 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
医療分析試験サービスの世界市場:現状分析と予測(2022年~2028年)
出版日: 2022年11月01日
発行: UnivDatos Market Insights Pvt Ltd
ページ情報: 英文 154 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界の医療分析試験サービスの市場規模は、予測期間中に約9%のCAGRで成長すると予測されています。新薬、バイオシミラー、配合剤、その他の革新的な医薬品の研究開発の増加、バイオシミラーや生物製剤の分析試験率の上昇、臨床試験数の大幅な増加、医薬品の研究・製造におけるクオリティ・バイ・デザイン手法の採用拡大は、市場の成長を促進しています。

当レポートでは、世界の医療分析試験サービス市場について調査しており、市場の洞察、市場動向、競合シナリオ、企業概要など、包括的な情報を提供しています。

目次

第1章 市場イントロダクション

  • 市場の定義
  • 主な目的
  • ステークホルダー
  • 制限

第2章 調査方法または仮定

  • 医療分析試験サービス市場の調査プロセス
  • 医療分析試験サービス市場の調査手法
  • 回答者プロファイル

第3章 市場要約

第4章 エグゼクティブサマリー

第5章 COVID-19が医療分析試験サービス市場に与える影響

第6章 医療分析試験サービス市場の収益(2022年~2028年)

第7章 市場の洞察:タイプ別

  • 生物分析試験サービス
  • 物理特性評価サービス
  • メソッド開発および検証試験サービス
  • 原材料試験サービス
  • バッチリリース試験サービス
  • 安定性試験
  • 微生物試験サービス
  • 環境モニタリングサービス

第8章 市場の洞察:エンドユーザー別

  • 医薬品およびバイオ医薬品企業
  • 医療機器企業
  • 臨研究機関

第9章 市場の洞察:地域別

  • 北米
    • 米国
    • カナダ
    • その他北米
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他アジア太平洋
  • 世界のその他の地域

第10章 医療分析試験サービス市場力学

  • 市場促進要因
  • 市場の課題
  • 影響分析

第11章 医療分析試験サービスの市場機会

第12章 医療分析試験サービスの市場動向

第13章 需要側と供給側の分析

  • 需要側分析
  • 供給側分析

第14章 バリューチェーン分析

第15章 競合シナリオ

  • 競合情勢
    • ポーターのファイブフォース分析

第16章 企業概要

  • Eurofins Scientific
  • Charles River Laboratories
  • Thermo Fisher Scientific
  • Merck KGAA
  • Danaher Corporation
  • Sartorius AG
  • Syneos Health
  • Almac Group
  • WuXi AppTec Co. Ltd.
  • SGS S.A.

第17章 免責事項

目次
Product Code: UMHE211283

Global Healthcare Analytical Testing Services Market is expected to grow at a significant rate of around 9% during the forecast period. The analytical testing of bulk drug materials, intermediates, finished pharmaceutical products, drug formulations, contaminants and degradation products, as well as biological samples containing the medications and their metabolites, is crucial in the field of pharmaceutical research. Thus, a rise in research and the development of new drugs, biosimilars, combination products, and other innovative medicines is creating the demand for different specific types of tests which in turn is driving the healthcare analytical testing services market globally. Furthermore, an increasing predominance of the analytical testing rate of biosimilar and biologics, a significant rise in the number of clinical trials and growing adoption of the quality-by-design approach in pharmaceutical research and manufacturing are some of the prominent factors contributing to the growth of the market.

Eurofins Scientific, Charles River Laboratories, Thermo Fisher Scientific, Merck KGAA, Danaher Corporation, Sartorius AG, Syneos Health, Almac Group, WuXi AppTec Co. Ltd., SGS S.A. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report

"Amongst type, bioanalytical testing services category to witness higher CAGR during the forecast period"

Based on the type, the healthcare analytical testing services market is segmented into bioanalytical testing services, physical characterization services, method development & validation testing services, raw material testing services, batch-release testing service, stability testing, microbial testing services, and environmental monitoring services. The bioanalytical testing services segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe as the utility of this service controls the cost of drug development.

"Amongst end-user, the pharmaceutical & biopharmaceutical companies to hold a significant share in the market in 2020"

Based on end-user, the market is fragmented into pharmaceutical & biopharmaceutical companies, medical device companies, and clinical research organizations. The pharmaceutical & biopharmaceutical companies segment is expected to grab a considerable market share in 2020 and is expected to grow with a lucrative CAGR during the forecast period as these businesses have a sizable need for analytical testing to support the numerous manufacturing and marketing operations, clinical trials, medication discovery, and drug development procedures.

"North America to hold a significant share in the market"

For a better understanding of the market adoption of the healthcare analytical testing services industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. The major factors such as well-established healthcare infrastructure, the presence of a number of top pharmaceutical and biopharmaceutical companies in the region, high investments in the biosimilars & biologics segment, and increasing R&D expenditure.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

The global healthcare analytical testing services market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Healthcare Analytical Testing Services Market
  • 2.2. Research Methodology of the Healthcare Analytical Testing Services Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET

6 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY TYPE

  • 7.1. Bioanalytical Testing Services
  • 7.2. Physical Characterization Services
  • 7.3. Method Development & Validation Testing Services
  • 7.4. Raw Material Testing Services
  • 7.5. Batch-Release Testing Services
  • 7.6. Stability Testing
  • 7.7. Microbial Testing Services
  • 7.8. Environmental Monitoring Services

8 MARKET INSIGHTS BY END-USER

  • 8.1. Pharmaceutical & Biopharmaceutical Companies
  • 8.2. Medical Device Companies
  • 8.3. Clinical Research Organizations

9 MARKET INSIGHTS BY REGION

  • 9.1. North America
    • 9.1.1. The U.S.
    • 9.1.2. Canada
    • 9.1.3. Rest of North America
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. The U.K.
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Rest of Asia-Pacific
  • 9.4. Rest of World

10 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET DYNAMICS

  • 10.1. Market Drivers
  • 10.2. Market Challenges
  • 10.3. Impact Analysis

11 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET OPPORTUNITIES

12 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 13.1. Demand Side Analysis
  • 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 COMPETITIVE SCENARIO

  • 15.1. Competitive Landscape
    • 15.1.1. Porters Fiver Forces Analysis

16 COMPANY PROFILED

  • 16.1. Eurofins Scientific
  • 16.2. Charles River Laboratories
  • 16.3. Thermo Fisher Scientific
  • 16.4. Merck KGAA
  • 16.5. Danaher Corporation
  • 16.6. Sartorius AG
  • 16.7. Syneos Health
  • 16.8. Almac Group
  • 16.9. WuXi AppTec Co. Ltd.
  • 16.10. SGS S.A.

17 DISCLAIMER